High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
暂无分享,去创建一个
M. Mayes | K. Sullivan | R. Storb | D. Furst | L. Crofford | M. Wener | K. McDonagh | C. Chen | P. Mcsweeney | T. Gooley | K. Russell | J. Storek | R. Nash | J. Nelson | L. Holmberg | K. Ryan | Julie Sunderhaus | R. Dansey | C. S. Chen | John Rambharose
[1] S. Vojvodić. [Immunologic reconstitution after hematopoietic stem cell transplantation--parameters of monitoring and current methods of its evaluation]. , 2002, Medicinski pregled.
[2] J. Snowden,et al. Collection of hematopoietic stem cells from patients with autoimmune diseases , 2001, Bone Marrow Transplantation.
[3] R. Storb,et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. , 2001, Blood.
[4] K. Sullivan,et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease , 2001, Annals of the rheumatic diseases.
[5] M. Mayes,et al. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial. , 2001, Arthritis and rheumatism.
[6] A. Nademanee,et al. Solid cancers after bone marrow transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] T. Medsger,et al. Severe organ involvement in systemic sclerosis with diffuse scleroderma. , 2000, Arthritis and rheumatism.
[8] S. Mujais,et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study , 2000, The Lancet.
[9] R. Wise,et al. Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and Alveolitis , 2000, Annals of Internal Medicine.
[10] L. Weiner,et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor , 2000, Neurology.
[11] C. Currie,et al. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. , 2000, Journal of hematotherapy & stem cell research.
[12] D. V. Bekkum. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation , 2000, Bone Marrow Transplantation.
[13] V. Leblond,et al. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] K. Atkinson. Clinical bone marrow and blood stem cell transplantation , 2000 .
[15] F. Berr,et al. A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] A. Silman,et al. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. , 1999, Arthritis and rheumatism.
[17] M. Mayes,et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. , 1999, Arthritis and rheumatism.
[18] P. Brooks,et al. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[19] E. Jaffe,et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. , 1999, Blood.
[20] F. Locatelli,et al. Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. , 1999, Rheumatology.
[21] Richard W. Martin,et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. , 1999, Arthritis and rheumatism.
[22] M. Schnitzler,et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.
[23] F. Locatelli,et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. , 1999, Arthritis and rheumatism.
[24] N. Schmitz,et al. Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality , 1999, Bone Marrow Transplantation.
[25] C. Peppas,et al. Intravenous Cyclophosphamide Pulse Therapy for the Treatment of Lung Disease Associated with Scleroderma , 1999, Clinical Rheumatology.
[26] D. Maloney,et al. Comparison of two flow cytometric methods enumerating CD4 T cells and CD8 T cells. , 1998, Cytometry.
[27] W. Gross,et al. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. , 1998, Arthritis and rheumatism.
[28] F. Appelbaum,et al. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system , 1998, Bone Marrow Transplantation.
[29] P. Lachenbruch,et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. , 1998, The Journal of rheumatology.
[30] J. Biggs,et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis , 1998, Bone Marrow Transplantation.
[31] T. Medsger,et al. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. , 1997, Arthritis and rheumatism.
[32] A. Anagnostopoulos,et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study , 1997, Bone Marrow Transplantation.
[33] Furst De,et al. Hypothesis for the pathogenesis of systemic sclerosis. , 1997 .
[34] Furst De,et al. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation. , 1997 .
[35] K. Sullivan,et al. Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. , 1997, The Journal of rheumatology. Supplement.
[36] K. Sullivan,et al. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. , 1997, The Journal of rheumatology. Supplement.
[37] K. Sullivan,et al. Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. , 1997, The Journal of rheumatology. Supplement.
[38] A. Gratwohl,et al. Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). , 1997, British journal of rheumatology.
[39] J. Winkler,et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation , 1997, The Lancet.
[40] D. Furst,et al. Hypothesis for the pathogenesis of systemic sclerosis. , 1997, The Journal of rheumatology. Supplement.
[41] D. Furst,et al. Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation. , 1997, The Journal of rheumatology. Supplement.
[42] M. Boeckh,et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. , 1996, Blood.
[43] I. Aref,et al. Severe fibrosis in a patient with scleroderma and previous radiotherapy—a case report and literature review , 1996 .
[44] C. Vogelmeier,et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. , 1996, American journal of respiratory and critical care medicine.
[45] F. Ortuño,et al. Immune recovery after autologous or rhG‐CSF primed PBSC transplantation , 1996, European journal of haematology.
[46] Malcolm K. Brenner,et al. Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.
[47] I. Aref,et al. Case report: severe fibrosis in a patient with scleroderma and previous radiotherapy--a case report and literature review. , 1996, The British journal of radiology.
[48] K. Weinberg,et al. The effect of thymic function on immunocompetence following bone marrow transplantation. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[49] R. Storb,et al. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. , 1995, Bone marrow transplantation.
[50] Richard W. Martin,et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. , 1995, The Journal of rheumatology.
[51] M. Levenstein,et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.
[52] R. Krance,et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.
[53] T. Medsger,et al. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study. , 1994, Arthritis and rheumatism.
[54] A. Lundin,et al. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. , 1994, Arthritis and rheumatism.
[55] E. Ashihara,et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. , 1994, Bone marrow transplantation.
[56] A. Silman,et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. , 1993, The Journal of rheumatology.
[57] L. To,et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. , 1993, Bone marrow transplantation.
[58] P. Lachenbruch,et al. The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo. , 1993, Arthritis and rheumatism.
[59] M. Abu-Shakra,et al. Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy. , 1993, The Journal of rheumatology.
[60] H. Deeg,et al. Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. , 1993, International journal of radiation oncology, biology, physics.
[61] R. Silver,et al. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. , 1993, The Journal of rheumatology.
[62] J. Giorgi,et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? , 1993, Bone marrow transplantation.
[63] S. Crawford,et al. Predictive value of pulmonary function tests before marrow transplantation. , 1992, Chest.
[64] J. Poole,et al. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. , 1991, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[65] P. Lachenbruch,et al. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. , 2010, Arthritis and rheumatism.
[66] P. Lachenbruch,et al. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. , 1989, Arthritis and rheumatism.
[67] F. Appelbaum,et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] M. Zutter,et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.
[69] M. Vadas,et al. Immune reconstitution following peripheral blood stem cell autografting. , 1987, Bone Marrow Transplantation.
[70] K. Sullivan,et al. Early and late interstitial pneumonia following human bone marrow transplantation. , 1986, International journal of cell cloning.
[71] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[72] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.
[73] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .